![Stephen G. Carter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen G. Carter
No más puestos en curso
Perfil
Stephen G.
Carter worked as the Director, Chief Scientific Officer & VP at Vaso Active Pharmaceuticals, Inc. from 2009 to 2012.
He also worked as the Chief Scientific Officer at Biochemics, Inc.
Antiguos cargos conocidos de Stephen G. Carter.
Empresas | Cargo | Fin |
---|---|---|
Vaso Active Pharmaceuticals, Inc.
![]() Vaso Active Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vaso Active Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The Company focuses on vaso active lipid encapsulated or VALE, transdermal delivery technology drugs. Currently, they market Athlete's Relief and Osteon in the United States. The Company's products, include Analgesics, Toenail fungal treatment, Acne, First aid, Hand and body lotion and Psoriasis treatment. It is planning to rebrand the deFEET athlete's foot anti-fungal medication product as Termin8 and Xtinguish. | Director Técnico/Científico/I+D | 06/11/2012 |
Biochemics, Inc.
![]() Biochemics, Inc. Household/Personal CareConsumer Non-Durables Biochemics, Inc. engages in the provision of pharmaceutical services. The company is headquartered in Danvers, MA. | Director Técnico/Científico/I+D | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Vaso Active Pharmaceuticals, Inc.
![]() Vaso Active Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vaso Active Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The Company focuses on vaso active lipid encapsulated or VALE, transdermal delivery technology drugs. Currently, they market Athlete's Relief and Osteon in the United States. The Company's products, include Analgesics, Toenail fungal treatment, Acne, First aid, Hand and body lotion and Psoriasis treatment. It is planning to rebrand the deFEET athlete's foot anti-fungal medication product as Termin8 and Xtinguish. | Health Technology |
Biochemics, Inc.
![]() Biochemics, Inc. Household/Personal CareConsumer Non-Durables Biochemics, Inc. engages in the provision of pharmaceutical services. The company is headquartered in Danvers, MA. | Consumer Non-Durables |
- Bolsa de valores
- Insiders
- Stephen G. Carter